Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-25 @ 9:38 PM
Study NCT ID:
NCT00883051
Status:
COMPLETED
Last Update Posted:
2019-12-23
First Post:
2009-04-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2010-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-02
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-16
First Submit QC Date:
None
Study First Post Date:
2009-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-08
Results First Submit QC Date:
None
Results First Post Date:
2019-12-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-20
Last Update Post Date:
2019-12-23
Last Update Post Date Type:
ACTUAL